share_log

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

輝瑞 | SC TO-I/A：發行招標公告
美股SEC公告 ·  08/22 23:19

牛牛AI助理已提取核心訊息

Pfizer Inc. has announced an amendment to its Tender Offer Statement on Schedule TO, filed with the SEC on August 12, 2024, regarding the Offer to Modify Eligible Performance Share Awards and Eligible Total Shareholder Return Units (TSRUs). The amendment, referred to as Amendment No. 1, supplements the original offer by removing references to continuous employment since July 24, 2024, and clarifying that all active employees of Pfizer and its wholly owned subsidiaries who hold Original Awards and reside in a country where Pfizer has granted Eligible TSRUs and/or Eligible PSAs are eligible to participate. The offer, which commenced on August 12, 2024, allows eligible participants to accept modifications to their performance share awards and TSRUs, potentially extending the performance period and vesting dates, among other changes. The expiration time for the offer is 11:59 p.m., Eastern Time, on September 12, 2024, unless extended. The offer is voluntary, and employees are not required to participate. Pfizer's stock, traded under the symbol 'PFE' on the NYSE, closed at $28.76 per share on August 8, 2024.
Pfizer Inc. has announced an amendment to its Tender Offer Statement on Schedule TO, filed with the SEC on August 12, 2024, regarding the Offer to Modify Eligible Performance Share Awards and Eligible Total Shareholder Return Units (TSRUs). The amendment, referred to as Amendment No. 1, supplements the original offer by removing references to continuous employment since July 24, 2024, and clarifying that all active employees of Pfizer and its wholly owned subsidiaries who hold Original Awards and reside in a country where Pfizer has granted Eligible TSRUs and/or Eligible PSAs are eligible to participate. The offer, which commenced on August 12, 2024, allows eligible participants to accept modifications to their performance share awards and TSRUs, potentially extending the performance period and vesting dates, among other changes. The expiration time for the offer is 11:59 p.m., Eastern Time, on September 12, 2024, unless extended. The offer is voluntary, and employees are not required to participate. Pfizer's stock, traded under the symbol 'PFE' on the NYSE, closed at $28.76 per share on August 8, 2024.
輝瑞公司已宣佈修訂其於2024年8月12日向美國證券交易委員會（SEC）提交的一份《計劃TO  的要約修訂聲明》（以下簡稱「修訂聲明1」），旨在修改符合條件的績效股票獎勵和符合條件的總股東回報單位（TSRU）的要約。修訂聲明1補充了原始要約，刪除了自2024年7月24日以來持續就業的相關內容，並明確規定所有持有原始獎勵、居住在輝瑞授予符合條件的TSRU和/或符合條件的PSA的國家的輝瑞及其全資子公司的在職員工都有資格參與。該要約於2024年8月12日開始，允許符合條件的參與者接受對其績效股票獎勵和TSRU的修改，可能延長績效期和兌現日期，以及其他變更。該要約的截止時間爲2024年9月12日晚上11:59（美國東部時間），除非延長。該要約是自願參與的，員工無需參與。輝瑞的股票在紐交所（NYSE）以「PFE」代碼進行交易，於2024年8月8日收盤價爲每股28.76美元。
輝瑞公司已宣佈修訂其於2024年8月12日向美國證券交易委員會（SEC）提交的一份《計劃TO  的要約修訂聲明》（以下簡稱「修訂聲明1」），旨在修改符合條件的績效股票獎勵和符合條件的總股東回報單位（TSRU）的要約。修訂聲明1補充了原始要約，刪除了自2024年7月24日以來持續就業的相關內容，並明確規定所有持有原始獎勵、居住在輝瑞授予符合條件的TSRU和/或符合條件的PSA的國家的輝瑞及其全資子公司的在職員工都有資格參與。該要約於2024年8月12日開始，允許符合條件的參與者接受對其績效股票獎勵和TSRU的修改，可能延長績效期和兌現日期，以及其他變更。該要約的截止時間爲2024年9月12日晚上11:59（美國東部時間），除非延長。該要約是自願參與的，員工無需參與。輝瑞的股票在紐交所（NYSE）以「PFE」代碼進行交易，於2024年8月8日收盤價爲每股28.76美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間